Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinic…
Biotechnology
US, San Diego [HQ]
Cash Flow Statement
14 Sheets · From 2022 to 2009Configuration
In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Cash Flow (OCF) | -20.00 | -15.00 | -11.00 | -16.00 | -29.00 | -32.00 | -50.00 | -68.00 | -64.00 | -70.00 | -147.00 | -271.00 | -388.00 | -570.00 | |
| Operating Cash (Net) | -20.00 | -15.00 | -11.00 | -16.00 | -29.00 | -32.00 | -50.00 | -68.00 | -64.00 | -70.00 | -147.00 | -271.00 | -388.00 | -570.00 | |
| Accounts Receivable | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Accounts Payable | - - | - - | - - | - - | - - | - - | 4.00 | 5.00 | -1.00 | 12.00 | 23.00 | 23.00 | 71.00 | -4.00 | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Change | - - | -1.00 | - - | 1.00 | - - | -1.00 | 3.00 | 4.00 | - - | 13.00 | 13.00 | 16.00 | 65.00 | -10.00 | |
| Other WC | - - | -1.00 | -1.00 | - - | - - | -1.00 | -1.00 | - - | - - | - - | -9.00 | -7.00 | -5.00 | -1.00 | |
| Investing Activities | |||||||||||||||
| Used Cash (Net) | 26.00 | 2.00 | -17.00 | - - | -29.00 | 24.00 | -50.00 | 38.00 | -8.00 | -145.00 | -176.00 | -139.00 | -588.00 | 225.00 | |
| Capital Expenditure | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -1.00 | -4.00 | -9.00 | -4.00 | |
| Purchases of Investments | -26.00 | -1.00 | -42.00 | -29.00 | -68.00 | -10.00 | -104.00 | -70.00 | -100.00 | -255.00 | -530.00 | -662.00 | -1,422.00 | -956.00 | |
| Sale/Maturity of Investment | 53.00 | 4.00 | 24.00 | 29.00 | 39.00 | 35.00 | 54.00 | 108.00 | 91.00 | 110.00 | 355.00 | 527.00 | 843.00 | 1,187.00 | |
| Property, Plant, Equipment (P&PE) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -1.00 | -4.00 | -9.00 | -4.00 | |
| Acquisitions (Net) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 174.00 | 135.00 | 579.00 | -230.00 | |
| Other Investing Activities | - - | - - | - - | - - | - - | 24.00 | -50.00 | 38.00 | -8.00 | -145.00 | -174.00 | -135.00 | -579.00 | 230.00 | |
| Financing Activities | |||||||||||||||
| Used Cash (Net) | -1.00 | -6.00 | -31.00 | -24.00 | -54.00 | - - | -144.00 | -2.00 | -158.00 | -140.00 | -338.00 | -1,250.00 | -505.00 | -166.00 | |
| Debt Repayment | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Dividends Paid | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Common Stock
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Issued | 1.00 | - - | 27.00 | 21.00 | 54.00 | - - | 143.00 | - - | 153.00 | 130.00 | 327.00 | 1,203.00 | 474.00 | 155.00 | |
| Repurchased | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Financing Activities | - - | 6.00 | 4.00 | 3.00 | - - | - - | 1.00 | 2.00 | 5.00 | 10.00 | 10.00 | 47.00 | 30.00 | 11.00 | |
| Cash Balances | |||||||||||||||
| Begin of Period | 5.00 | 14.00 | 7.00 | 10.00 | 18.00 | 14.00 | 6.00 | 49.00 | 22.00 | 107.00 | 32.00 | 46.00 | 886.00 | 413.00 | |
| End of Period | 13.00 | 7.00 | 9.00 | 18.00 | 14.00 | 6.00 | 49.00 | 22.00 | 107.00 | 32.00 | 46.00 | 886.00 | 413.00 | 235.00 | |
| Change | 7.00 | -6.00 | 2.00 | 8.00 | -4.00 | -7.00 | 42.00 | -27.00 | 85.00 | -75.00 | 14.00 | 839.00 | -472.00 | -177.00 | |
| Non-Cash Balances | |||||||||||||||
| Depreciation and Amortization | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 1.00 | 2.00 | |
| Stock Based Compensation | - - | - - | - - | 2.00 | 3.00 | 7.00 | 10.00 | 10.00 | 6.00 | 15.00 | 55.00 | 85.00 | 113.00 | 186.00 | |
| Other | - - | - - | -2.00 | - - | - - | - - | - - | - - | - - | -1.00 | -3.00 | -11.00 | 12.00 | -8.00 | |
| Highlighted metrics | |||||||||||||||
| Free Cash Flow (FCF) | -20.00 | -15.00 | -11.00 | -17.00 | -29.00 | -33.00 | -51.00 | -68.00 | -64.00 | -70.00 | -149.00 | -275.00 | -398.00 | -575.00 | |
| Cash Conversion Cycle (CCC) | - - | - - | - - | - - | - - | - - | - - | - - | - - | -81.00 | 72.00 | 37.00 | -14.00 | -21,777.00 | |
| Invested Capital | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
|||||||||||||||
| Forex Effect on Cash | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - |